| Market cap | N/A |
|---|---|
| P/E | N/A |
| EPS | N/A |
| Div yield | N/A |
| 52W high | R32.87 |
| 52W low | R30.24 |
| Volume | 77 |
| Listed | N/A |
Price and fundamentals data is supplied by EODHD, with Yahoo Finance as a fallback source. Sentiment is computed by StockTalk SA from live member stances recorded by registered members on this page.
SYGH at R31.04 gives you pure healthcare exposure without the single-stock risk, whereas something like Satrix MSCI World might dilute your sector bet across everything. The ETF's tracking a niche index so you're paying for conviction in healthcare fundamentals rather than broad
SYGH at R32.35 gives you focused healthcare exposure versus the broader Satrix 40 ETF, though you're taking on sector concentration risk. The dividend yield on healthcare plays tends to lag the general market, but if you reckon pharma and med devices are set for a run then this b
SYGH at R31.45 offers reasonable exposure to global healthcare at a time when developed market healthcare valuations remain elevated but defensive. The fund's ability to capture upside from innovation plays is tempered by currency headwinds and the fact that you're paying for mat